EthOss has welcomed one of the industry’s most experienced figures to its growing team.
Werner Blessing – who has more than 20 years’ experience in the dental implant and bone grafting sector, has joined UK-based EthOss to help build the company’s clinical network across Europe.
The new role with the company will also see Mr Blessing – former CEO of one of the world’s biggest bone grafting firms – focus on the development of EthOss’s education and training arm, The EthOss Academy.
Blessing, said: “I’m thrilled to be joining EthOss at such an exciting time, as the company completes its best ever year in business and continues to build its reputation around the globe.
“What the team have come up with is truly pioneering. When I first read about EthOss® I couldn’t believe it at first – the results gained and the innovative technique used – but having seen it all for myself now, the potential is amazing.
“I’m proud to be joining the company and lending my experience in the industry to help EthOss continue to grow.”
EthOss’s success has been driven by the creation of a fully-synthetic material that works with the body to create the ideal conditions for bone regrowth, without using animal or human content.
The product – EthOss® – is made from a mixture of beta Tricalcium Phosphate and Calcium Sulphate. The Calcium Sulphate acts as a built-in barrier against soft tissue ingress, removing the need for an additional collagen membrane – a very popular feature with dentists who often find collagen membranes difficult to handle and an expensive addition to a procedure.
The material is mixed into a paste and applied to the surgical site using a simple syringe delivery system. Once applied, EthOss® becomes firm and forms a semi rigid graft providing a highly stable scaffold, leading to impressive clinical success rates of 50% new bone after 12 weeks.
Dr Paul Harrison, Managing Director of EthOss Regeneration, said: “It’s fantastic to welcome Werner to our team, his reputation within our industry is truly impressive and to have someone of his calibre on board shows our intent to become the global market leader in bone regeneration technologies.”
The appointment comes just weeks after the company announced its best ever year, with turnover increasing by almost 60 percent during the last 12 months thanks to its growing presence in export markets around the globe.
Over the last year the company has signed agreements with distributors in countries including Spain, Sweden, Switzerland, Jordan, Australia and New Zealand. As a result of this, export sales have increased to £1.1m in 2019, a 148% increase on 2018.